MARKET

NWPHF

NWPHF

Newron Phar
Grey
2.100
NaN%
Closed 09:30 02/06 EST
OPEN
--
PREV CLOSE
2.800
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.100
52 WEEK LOW
2.100
MARKET CAP
41.92M
P/E (TTM)
1.308
1D
5D
1M
3M
1Y
5Y
1D
Newron’s Evenamide Shows Durable Benefits as Add-On Therapy in Treatment-Resistant Schizophrenia
TipRanks · 5d ago
Analysts Conflicted on These Healthcare Names: Arcturus Therapeutics (ARCT), Newron Pharmaceuticals SpA (OtherNWPHF) and Aldeyra Therapeutics (ALDX)
TipRanks · 01/21 15:20
Newron Pharma price target raised to CHF 43 from CHF 26 at H.C. Wainwright
TipRanks · 01/12 11:10
EA Pharma Starts Phase III Trial of Newron’s Evenamide for Treatment‑Resistant Schizophrenia in Japan
TipRanks · 01/07 06:33
Newron Secures EU Patent Extension for Lead Schizophrenia Drug Evenamide
TipRanks · 01/06 06:33
Newron Wins Long-Term EU Patent Protection for Lead Schizophrenia Drug Evenamide
TipRanks · 01/06 06:32
Newron Pharma initiated with a Buy at Lucid Capital
TipRanks · 12/11/2025 11:50
Newron Pharmaceuticals’ Evenamide Advances with ENIGMA-TRS 2 Trial: Analyst Reiterates Buy Rating
TipRanks · 12/11/2025 11:16
More
About NWPHF
Newron Pharmaceuticals SpA is an Italy-based clinical-stage biopharmaceutical company. It focuses on the discovery and development of pharmaceutical products. The Company is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The Company undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson’s disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Its additional projects, such as HF0220 for neuroprotection, NW-3509 for the treatment of schizophrenia, as well as pruvanserin and sarizotan for treatment of CNS diseases, are at various stages of preclinical and clinical development.

Webull offers Newron Pharmaceuticals SpA stock information, including Grey: NWPHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NWPHF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NWPHF stock methods without spending real money on the virtual paper trading platform.